The Risk Of Recurrence In Prostate Cancer

The Risk Of Recurrence In Prostate Cancer
By Fritz Frei

Prostate disease

Prostate - the most common form of in men is
Prostate cancer, the second leading cause of death. The
Main risk factors include age (incidence increases in men over
the age of 65 years). It is more prevalent in the western world
and about 10% of cases can be linked to family history. The
recurrance Rate of the prostate is high.

Mostly, the Prostate is a continuum; progressing through
localized, locally advanced, advanced and hormone-refractory
stages In general it is a slow growing cancer. He is primarily
under hormonal control i.e. testosterone. The choice of
treatments which include watchful waiting, surgery
(prostatectomy), radiotherapy, hormonal therapy and chemotherapy
are dependent on the stage of disease.

1. Most important, that If detected early, using PSA
determination, DRE examination and biopsies, and treated
appropriately, survival rates are excellent.

2. The most critical focus for the treatment of prostate cancer
is to treat those cancers where it is necessary.

3. The Decisions about the best management of prostate cancer
can be very complex and depend upon the:

- Pathology of the (unlike other cancers, prostate
cancer often progresses very slowly)
- The impact that treatment can have on quality of life,
including sexual activity
- Stage of the disease (non-metastatic (localized or locally
advanced), metastatic or hormone refractory)
- Age and general health of the patients at diagnosis
- Patient’s preference for treatment
- PSA at diagnosis

4. The treatment options for prostate are:

- Deferred treatment often called ‘watchful waiting’ or 'active
surveillance'
- Surgery – Radical Prostatectomy
- Radiotherapy – External Beam and/or Brachytherapy
- Hormonal (endocrine) therapy – Androgen Ablation e.g.
anti-androgens, medical castration (LHRHa) or surgical
castration
- Chemotherapy
- Palliative Therapy e.g. chemotherapy
- Investigational Therapies

Prostate Recurrence Rates ***

Prostate is now detected at earlier stages due to
heightened awareness and improved screening techniques. Despite
definitive therapy, cells may remain and can go
undetected for years until they develop

into metastatic disease.
The risk of recurrence is high, suggesting there is a need to
improve treatment approaches. Therefore, it is important to
predict pathological stage and risk of disease recurrence early,
so that appropriate treatment and/or monitoring can be
initiated. The result's of all new treatments will bring us in
the future the chance of a lower prostate recurrance.

**You can inform you about the recurrence Rates on:

http://www.prostateline.com/prostatelinehcp/9898_15850_8_0_0.aspx

This gives you an overview with a study case – and the results.

Please, take note that the above information is for educational
purposes only and is meant to complement any medical treatment,
not to prescribe or diagnose any
condition.

Please consult with your doctor before starting any medical or
nutritional program.Recognizing diabetes mellitus is difficult
already

About the Author: Health-Service-Online bring's the problems of
cancer on the point! Everybody can check out the new's of the
risk of prostate - the recurrance rate is high and there
is most important - to check out this desease early!
Health-Service-Online. Admin Fritz  http://www.cancer-info.info

Source: http://www.isnare.com

Permanent Link:
http://www.isnare.com/?aid=13320&ca=Wellness%2C+Fitness+and+Diet